HG Stock Analysis: Hamilton Insurance | NYSE
Insurance - Reinsurance | NYSE, USA | Market Cap: 3.438m USD | 12M Return: 64.7% | BMG427061046 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.8M
Qual. Beats: 6
Rev. Trend: 92.6%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 2.9 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Hamilton Insurance Group, Ltd. (NYSE: HG) is a specialty insurance and reinsurance company headquartered in Pembroke, Bermuda, operating both domestically and internationally. Founded in 2013, the company runs three underwriting platforms-Hamilton Global Specialty, Hamilton Select, and Hamilton Re-offering a broad portfolio that spans casualty and property reinsurance, specialty reinsurance solutions, and a wide range of commercial insurance lines including cyber, energy, marine, aviation, political risk, professional liability, and surety products.
Bermuda is a globally significant hub for the reinsurance industry, hosting many major carriers due to its favorable regulatory and tax environment. Hamilton went public on the NYSE in November 2023 and is classified within the Financials sector under the Reinsurance sub-industry, with a mid-cap market capitalization.
- Catastrophe losses pressure combined ratio and underwriting margins
- Specialty insurance pricing softens amid rising competition
- Higher rates boost investment income on insurance float
| Net Income: 585.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.11 > 1.0 |
| NWC/Revenue: -192.9% < 20% (prev -214.4%; Δ 21.41% < -1%) |
| CFO/TA 0.08 > 3% & CFO 815.2m > Net Income 585.7m |
| Net Debt (-4.04b) to EBITDA (881.7m): -4.58 < 3 |
| Current Ratio: 0.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (101.5m) vs 12m ago 0.0% < -2% |
| Gross Margin: 52.56% > 18% (prev 38.45%; Δ 14.11% > 0.5%) |
| Asset Turnover: 31.19% > 50% (prev 24.51%; Δ 6.68% > 0%) |
| Interest Coverage Ratio: 44.65 > 6 (EBIT TTM 866.0m / Interest Expense TTM 19.4m) |
| A: -0.56 (Total Current Assets 829.0m - Total Current Liabilities 6.60b) / Total Assets 10.3b |
| B: 0.17 (Retained Earnings 1.73b / Total Assets 10.3b) |
| C: 0.09 (EBIT TTM 866.0m / Avg Total Assets 9.59b) |
| D: 0.39 (Book Value of Equity 2.85b / Total Liabilities 7.34b) |
| Altman-Z'' = -2.12 = D |
| DSRI: 0.37 (Receivables 1.24b/2.46b, Revenue 2.99b/2.18b) |
| GMI: 0.73 (GM 38.45% / 52.56%) |
| AQI: 1.05 (AQ_t 0.92 / AQ_t-1 0.88) |
| SGI: 1.37 (Revenue 2.99b / 2.18b) |
| TATA: -0.02 (NI 585.7m - CFO 815.2m) / TA 10.3b) |
| Beneish M = -3.50 (Cap -4..+1) = AA |
As of October 17, 2026, the stock is trading at USD 36.21 with a total of 302,968 shares traded. Over the past week, the price has changed by +4.90%, over one month by +2.96%, over three months by +5.05% and over the past year by +64.67%.
Current recommended Stop Loss: 35.00 (which is 3.3% or 1.5 ATR below the current price).
Hamilton Insurance has received a consensus analysts rating of 3.71. Therefore, it is recommended to hold HG.
- StrongBuy: 1
- Buy: 3
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 38.3 | 5.7% |
P/E Trailing = 6.0944
P/S = 1.1492
P/B = 1.1578
Revenue TTM = 2.99b USD
EBIT TTM = 866.0m USD
EBITDA TTM = 881.7m USD
Long Term Debt = 149.8m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 149.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.04b USD (calculated: Debt 149.8m - CCE 4.19b)
Enterprise Value = 3.44b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 44.65 (Ebit TTM 866.0m / Interest Expense TTM 19.4m)
EV/FCF = 4.22x (Enterprise Value 3.44b / FCF TTM 815.2m)
FCF Yield = 23.71% (FCF TTM 815.2m / Enterprise Value 3.44b)
FCF Margin = 27.26% (FCF TTM 815.2m / Revenue TTM 2.99b)
Net Margin = 19.58% (Net Income TTM 585.7m / Revenue TTM 2.99b)
Gross Margin = 52.56% ((Revenue TTM 2.99b - Cost of Revenue TTM 1.42b) / Revenue TTM)
Gross Margin QoQ = 57.31% (prev 56.95%)
Tobins Q-Ratio = 0.33 (Enterprise Value 3.44b / Total Assets 10.3b)
Interest Expense / Debt = 12.95% (Interest Expense 19.4m / Debt 149.8m)
Taxrate = 0.96% (2.47m / 257.3m)
NOPAT = 857.7m (EBIT 866.0m * (1 - 0.96%))
Current Ratio = 0.13 (Total Current Assets 829.0m / Total Current Liabilities 6.60b)
Debt / Equity = 0.05 (Debt 149.8m / totalStockholderEquity, last quarter 2.85b)
Debt / EBITDA = -4.58 (Net Debt -4.04b / EBITDA 881.7m)
Debt / FCF = -4.95 (Net Debt -4.04b / FCF TTM 815.2m)
Total Stockholder Equity = 2.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.11% (Net Income 585.7m / Total Assets 10.3b)
RoE = 21.19% (Net Income TTM 585.7m / Total Stockholder Equity 2.76b)
RoCE = 29.72% (EBIT 866.0m / Capital Employed (Equity 2.76b + L.T.Debt 149.8m))
RoIC = 24.40% (NOPAT 857.7m / Invested Capital 3.51b)
WACC = 6.32% (E(3.44b)/V(3.59b) * Re(6.04%) + D(149.8m)/V(3.59b) * Rd(12.95%) * (1-Tc(0.01)))
Discount Rate = 6.04% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -61.05 | Cagr: -3.91%
[DCF] Terminal Value 77.97% ; FCFF base≈768.3m ; Y1≈880.7m ; Y5≈1.30b
[DCF] Fair Price = 357.3 (EV 19.5b - Net Debt -4.04b = Equity 23.5b / Shares 65.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.62 | # QB: 6
Revenue Correlation: 92.58 | Revenue CAGR: 29.46% | SUE: 2.07 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.88 | Chg30d=+12.49% | Revisions=+44% | Analysts=7
EPS current Year (2026-12-31): EPS=5.06 | Chg30d=+1.61% | Revisions=+70% | GrowthEPS=+4.6% | GrowthRev=+5.5%
EPS next Year (2027-12-31): EPS=4.77 | Chg30d=+0.81% | Revisions=+25% | GrowthEPS=-5.7% | GrowthRev=+3.1%
[Analyst] Revisions Ratio: +71% (up=13, down=1)